Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Seratrodast, a novel benzoquinone derivative, is the first thromboxane A2 (TxA2) receptor antagonist to reach the market. It is a pale orange solid, available under the brand name Bronica. Seratrodast is orally active for the treatment of bronchospastic disorders such as asthma. TxA2, a metabolite of the arachidonate cascade, is involved in several cardiovascular and respiratory diseases through its potent biological effects on platelet aggregation and constriction of vascular and respiratory smooth muscles. Seratrodast potently inhibits platelet aggregation and bronchoconstriction induced by a TxA2 mimic and by a variety of spasmogenic prostanoids including PGF2α, PGD2, and 9α,11β-PGF2. Seratrodast shows excellent efficacy in asthma and has been reported to be potentially useful in hyper-responsive disorder. The R-(+)seratrodast was reported to be the active isomer.

112665-43-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 112665-43-7 Structure
  • Basic information

    1. Product Name: Seratrodast
    2. Synonyms: benzeneheptanoic acid, -(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-;(+-)-7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoicacid;aa-2414;beta-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-bezeneheptanoicaci;5-(2,4,5-trimethyl-3,6,-dioxo-1,4-cyclohexadien-1-yl)benzeneheptanoic acid;7-(3,5,6-trimethy1-1,4-benzoquinon-2-y1)-7-phenylheptanoic acid;7-phenyl-7-(2,4,5-trimethyl-3,6-dioxo-1-cyclohexa-1,4-dienyl)heptanoic acid; Abbott 73001
    3. CAS NO:112665-43-7
    4. Molecular Formula: C22H26O4
    5. Molecular Weight: 354.44
    6. EINECS: 1312995-182-4
    7. Product Categories: ZAGAM;API;Heterocyclic Compounds;Intermediates & Fine Chemicals;Pharmaceuticals
    8. Mol File: 112665-43-7.mol
  • Chemical Properties

    1. Melting Point: 118-120°C
    2. Boiling Point: 522.3 °C at 760 mmHg
    3. Flash Point: 283.8 °C
    4. Appearance: pale orange solid
    5. Density: 1.14 g/cm3
    6. Vapor Pressure: 0.002mmHg at 25°C
    7. Refractive Index: 1.584
    8. Storage Temp.: Store at +4°C
    9. Solubility: Chloroform (Slightly), Methanol (Slightly)
    10. PKA: 4.76±0.10(Predicted)
    11. Merck: 14,8459
    12. CAS DataBase Reference: Seratrodast(CAS DataBase Reference)
    13. NIST Chemistry Reference: Seratrodast(112665-43-7)
    14. EPA Substance Registry System: Seratrodast(112665-43-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS: DA1600050
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 112665-43-7(Hazardous Substances Data)

112665-43-7 Usage

Uses

1. Used in Pharmaceutical Industry:
Seratrododast is used as a Thromboxane A2-receptor antagonist for the treatment of bronchospastic disorders such as asthma. It helps in inhibiting platelet aggregation and bronchoconstriction, providing relief from asthma symptoms.
2. Used in Respiratory Medicine:
Seratrodast is used as an antiasthmatic agent, particularly for patients with hyper-responsive disorders. It effectively reduces the frequency and severity of asthma attacks by blocking the effects of thromboxane A2 on respiratory smooth muscles.
3. Used in Antibacterial Applications:
Although not explicitly mentioned in the provided materials, Seratrodast's potential antibacterial properties could be explored for use in the development of new antibiotics or as a component in existing treatments.

Originator

Takeda (Japan)

Biological Activity

Thromboxane A 2 (TP) receptor antagonist. Antiasthmatic agent; inhibits platelet aggregation and bronchoconstriction induced by a TXA 2 mimetic in guinea pigs.

in vitro

seratrodast was found to inhibit the aggregation of guinea pig platelets induced by a prostaglandin endoperoxide analogue, u-44069 and the specific binding of another analogue, [3h]u-46619 to washed guinea pig platelets. seratrodast could competitively inhibit the contraction of rabbit aorta and pig coronary arteries induced by u-44069. seratrodast also inhibited the contraction of rabbit aorta induced by pgf2 alpha and the contraction of pig coronary arteries. however, seratrodast had no effect on the antiaggregatory effect of guinea pig platelets [1].

in vivo

in experiments with guinea pigs, oral seratrodast at 0.1-1 mg/kg could dose-dependently inhibit the platelet aggregation induced by u-44069; the inhibition at 1 mg/kg was 100% at 1 hr and was 89% even at 24 hr after seratrodast administration [1].

IC 50

7.4 nm for guinea pig platelets

references

[1] imura, y. ,terashita, z.,shibouta, y., et al. antagonistic action of aa-2414 on thromboxane a2/prostaglandin endoperoxide receptor in platelets and blood vessels. japanese journal of pharmacology 52(1), 35-53 (1990).

Check Digit Verification of cas no

The CAS Registry Mumber 112665-43-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,2,6,6 and 5 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 112665-43:
(8*1)+(7*1)+(6*2)+(5*6)+(4*6)+(3*5)+(2*4)+(1*3)=107
107 % 10 = 7
So 112665-43-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H9N3O2/c1-9-5(7)4(3-8-9)6(10)11-2/h3H,7H2,1-2H3

112665-43-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (S0943)  Seratrodast  >98.0%(HPLC)(T)

  • 112665-43-7

  • 100mg

  • 490.00CNY

  • Detail
  • TCI America

  • (S0943)  Seratrodast  >98.0%(HPLC)(T)

  • 112665-43-7

  • 1g

  • 1,990.00CNY

  • Detail
  • Sigma

  • (SML1379)  Seratrodast  ≥98% (HPLC)

  • 112665-43-7

  • SML1379-10MG

  • 609.57CNY

  • Detail
  • Sigma

  • (SML1379)  Seratrodast  ≥98% (HPLC)

  • 112665-43-7

  • SML1379-50MG

  • 2,476.89CNY

  • Detail

112665-43-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name Seratrodast

1.2 Other means of identification

Product number -
Other names 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)heptanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:112665-43-7 SDS

112665-43-7Synthetic route

1,4-dimethoxy-2,3,5-trimethyl-benzene
4537-09-1

1,4-dimethoxy-2,3,5-trimethyl-benzene

C13H19NO2

C13H19NO2

seratrodast
112665-43-7

seratrodast

Conditions
ConditionsYield
Stage #1: 1,4-dimethoxy-2,3,5-trimethyl-benzene; C13H19NO2 With sodium nitrate; aluminum isopropoxide at 47℃; for 2h;
Stage #2: With dipotassium peroxodisulfate; sodium sulfate at 55℃; for 0.833333h;
Stage #3: With niobium(V) oxide for 3.6h; Temperature;
99.2%
potassium nitrosodisulfonate (Fremy's salt)

potassium nitrosodisulfonate (Fremy's salt)

7-(2-hydroxy-3,4,6-trimethylphenyl)-7-phenylheptanoic acid
148989-82-6

7-(2-hydroxy-3,4,6-trimethylphenyl)-7-phenylheptanoic acid

seratrodast
112665-43-7

seratrodast

Conditions
ConditionsYield
With ammonium hydroxide In water; acetonitrile94.1%
Trimethylhydroquinone
700-13-0

Trimethylhydroquinone

boron trifluoride diethyl etherate
109-63-7

boron trifluoride diethyl etherate

7-hydroxy-7-phenylheptanoic acid
103187-18-4

7-hydroxy-7-phenylheptanoic acid

seratrodast
112665-43-7

seratrodast

Conditions
ConditionsYield
With iron(III) chloride In tetrahydrofuran; water; toluene73%
2,3,5-Trimethyl-1,4-benzoquinone
935-92-2

2,3,5-Trimethyl-1,4-benzoquinone

phenyl-2-oxocanone

phenyl-2-oxocanone

seratrodast
112665-43-7

seratrodast

Conditions
ConditionsYield
Stage #1: 2,3,5-Trimethyl-1,4-benzoquinone; phenyl-2-oxocanone With diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate at 20℃; for 0.5h;
Stage #2: With hafnium tetrakis(trifluoromethanesulfonate) at 40℃; for 6h;
46%
7-(2,5-Dihydroxy-3,4,6-trimethyl-phenyl)-7-phenyl-heptanoic acid
148989-73-5

7-(2,5-Dihydroxy-3,4,6-trimethyl-phenyl)-7-phenyl-heptanoic acid

seratrodast
112665-43-7

seratrodast

Conditions
ConditionsYield
With iron(III) chloride In tetrahydrofuran for 0.5h; Ambient temperature; Yield given;
With iron(III) chloride In tetrahydrofuran at 25℃; for 0.5h; Inert atmosphere;
ethyl 6-(chloroformyl)hexanoate
14794-32-2

ethyl 6-(chloroformyl)hexanoate

seratrodast
112665-43-7

seratrodast

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: AlCl3 / 2 h / 90 °C
2: NaBH4 / methanol / 0.5 h / 0 °C
3: 95 percent / 2.5 N NaOH / tetrahydrofuran / 3 h / 70 °C
4: boron trifluoride etherate / toluene / 2 h / 60 °C
5: aq. FeCl3 / tetrahydrofuran / 0.5 h / Ambient temperature
View Scheme
7-ethoxy-7-oxoheptanoic acid
33018-91-6

7-ethoxy-7-oxoheptanoic acid

seratrodast
112665-43-7

seratrodast

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 98 percent / SOCl2 / CH2Cl2 / 2 h / 50 °C
2: AlCl3 / 2 h / 90 °C
3: NaBH4 / methanol / 0.5 h / 0 °C
4: 95 percent / 2.5 N NaOH / tetrahydrofuran / 3 h / 70 °C
5: boron trifluoride etherate / toluene / 2 h / 60 °C
6: aq. FeCl3 / tetrahydrofuran / 0.5 h / Ambient temperature
View Scheme
ethyl 7-oxo-7-phenylheptanoate
112665-41-5

ethyl 7-oxo-7-phenylheptanoate

seratrodast
112665-43-7

seratrodast

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: NaBH4 / methanol / 0.5 h / 0 °C
2: 95 percent / 2.5 N NaOH / tetrahydrofuran / 3 h / 70 °C
3: boron trifluoride etherate / toluene / 2 h / 60 °C
4: aq. FeCl3 / tetrahydrofuran / 0.5 h / Ambient temperature
View Scheme
7-hydroxy-7-phenyl-heptanoic acid ethyl ester
112665-42-6

7-hydroxy-7-phenyl-heptanoic acid ethyl ester

seratrodast
112665-43-7

seratrodast

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 95 percent / 2.5 N NaOH / tetrahydrofuran / 3 h / 70 °C
2: boron trifluoride etherate / toluene / 2 h / 60 °C
3: aq. FeCl3 / tetrahydrofuran / 0.5 h / Ambient temperature
View Scheme
7-hydroxy-7-phenylheptanoic acid
103187-18-4

7-hydroxy-7-phenylheptanoic acid

seratrodast
112665-43-7

seratrodast

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: boron trifluoride etherate / toluene / 2 h / 60 °C
2: aq. FeCl3 / tetrahydrofuran / 0.5 h / Ambient temperature
View Scheme
bromobenzene
108-86-1

bromobenzene

seratrodast
112665-43-7

seratrodast

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: magnesium; iodine / tetrahydrofuran / 1 h / Sealed tube; Inert atmosphere; Reflux
1.2: 20 °C / Sealed tube; Inert atmosphere
1.3: Sealed tube; Inert atmosphere; Reflux; Dean-Stark
2.1: borane-THF / tetrahydrofuran / 2.5 h / 20 °C / Sealed tube; Inert atmosphere
2.2: 4 h / 20 °C / Sealed tube; Inert atmosphere
3.1: pyridinium chlorochromate / dichloromethane / 24 h / 0 - 20 °C
4.1: 3-chloro-benzenecarboperoxoic acid / dichloromethane / 16 h / 35 °C / Inert atmosphere; Sealed tube
5.1: diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate / 0.5 h / 20 °C
5.2: 6 h / 40 °C
View Scheme
cycloheptanone
502-42-1

cycloheptanone

seratrodast
112665-43-7

seratrodast

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: magnesium; iodine / tetrahydrofuran / 1 h / Sealed tube; Inert atmosphere; Reflux
1.2: 20 °C / Sealed tube; Inert atmosphere
1.3: Sealed tube; Inert atmosphere; Reflux; Dean-Stark
2.1: borane-THF / tetrahydrofuran / 2.5 h / 20 °C / Sealed tube; Inert atmosphere
2.2: 4 h / 20 °C / Sealed tube; Inert atmosphere
3.1: pyridinium chlorochromate / dichloromethane / 24 h / 0 - 20 °C
4.1: 3-chloro-benzenecarboperoxoic acid / dichloromethane / 16 h / 35 °C / Inert atmosphere; Sealed tube
5.1: diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate / 0.5 h / 20 °C
5.2: 6 h / 40 °C
View Scheme
seratrodast
112665-43-7

seratrodast

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: borane-THF / tetrahydrofuran / 2.5 h / 20 °C / Sealed tube; Inert atmosphere
1.2: 4 h / 20 °C / Sealed tube; Inert atmosphere
2.1: pyridinium chlorochromate / dichloromethane / 24 h / 0 - 20 °C
3.1: 3-chloro-benzenecarboperoxoic acid / dichloromethane / 16 h / 35 °C / Inert atmosphere; Sealed tube
4.1: diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate / 0.5 h / 20 °C
4.2: 6 h / 40 °C
View Scheme
2-phenylcycloheptan-1-ol
92035-59-1

2-phenylcycloheptan-1-ol

seratrodast
112665-43-7

seratrodast

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: pyridinium chlorochromate / dichloromethane / 24 h / 0 - 20 °C
2.1: 3-chloro-benzenecarboperoxoic acid / dichloromethane / 16 h / 35 °C / Inert atmosphere; Sealed tube
3.1: diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate / 0.5 h / 20 °C
3.2: 6 h / 40 °C
View Scheme
2-phenylcycloheptanone
14996-78-2

2-phenylcycloheptanone

seratrodast
112665-43-7

seratrodast

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: 3-chloro-benzenecarboperoxoic acid / dichloromethane / 16 h / 35 °C / Inert atmosphere; Sealed tube
2.1: diethyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate / 0.5 h / 20 °C
2.2: 6 h / 40 °C
View Scheme
2-(N-tert-butoxycarbonylamino)ethanol
26690-80-2

2-(N-tert-butoxycarbonylamino)ethanol

seratrodast
112665-43-7

seratrodast

C29H39NO6

C29H39NO6

Conditions
ConditionsYield
With dmap In dichloromethane; N,N-dimethyl-formamide at 20℃; Cooling with ice;100%
methanol
67-56-1

methanol

seratrodast
112665-43-7

seratrodast

6-(6-methoxycarbonyl-1-phenylhexyl)-2,3,5-trimethylbenzoquinone

6-(6-methoxycarbonyl-1-phenylhexyl)-2,3,5-trimethylbenzoquinone

Conditions
ConditionsYield
With sulfuric acid at 80℃; for 2h;98%
4-nitro-phenol
100-02-7

4-nitro-phenol

seratrodast
112665-43-7

seratrodast

p-nitrophenyl 7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoate
112665-40-4

p-nitrophenyl 7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoate

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In dichloromethane 1) 0 deg C, 30 min, 2) room temperature, 1 h;91%
seratrodast
112665-43-7

seratrodast

7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanamide

7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 91 percent / dicyclohexyl carbodiimide / CH2Cl2 / 1) 0 deg C, 30 min, 2) room temperature, 1 h
2: 87 percent / aq. conc. ammonia / tetrahydrofuran / 4 h / Ambient temperature
View Scheme
seratrodast
112665-43-7

seratrodast

7-Phenyl-7-(2,4,5-trimethyl-3,6-dioxo-cyclohexa-1,4-dienyl)-heptanoic acid isopropylamide

7-Phenyl-7-(2,4,5-trimethyl-3,6-dioxo-cyclohexa-1,4-dienyl)-heptanoic acid isopropylamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 91 percent / dicyclohexyl carbodiimide / CH2Cl2 / 1) 0 deg C, 30 min, 2) room temperature, 1 h
2: 81 percent / tetrahydrofuran / Ambient temperature
View Scheme
seratrodast
112665-43-7

seratrodast

7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoylglycine

7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoylglycine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 91 percent / dicyclohexyl carbodiimide / CH2Cl2 / 1) 0 deg C, 30 min, 2) room temperature, 1 h
View Scheme
seratrodast
112665-43-7

seratrodast

7-Phenyl-7-(2,4,5-trimethyl-3,6-dioxo-cyclohexa-1,4-dienyl)-heptanoic acid (1-phenyl-ethyl)-amide

7-Phenyl-7-(2,4,5-trimethyl-3,6-dioxo-cyclohexa-1,4-dienyl)-heptanoic acid (1-phenyl-ethyl)-amide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 91 percent / dicyclohexyl carbodiimide / CH2Cl2 / 1) 0 deg C, 30 min, 2) room temperature, 1 h
2: 85 percent / tetrahydrofuran / Ambient temperature
View Scheme
4-(N-imidazolyl)aniline
2221-00-3

4-(N-imidazolyl)aniline

seratrodast
112665-43-7

seratrodast

N-[4-(imidazol-1-yl)phenyl]-7-phenyl-4-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)heptanamide

N-[4-(imidazol-1-yl)phenyl]-7-phenyl-4-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)heptanamide

Conditions
ConditionsYield
With benzotriazol-1-ol; triethylamine; 1-ethyl-3-(3-dimethylamino-propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 20h;
seratrodast
112665-43-7

seratrodast

6-(6-methoxycarbonyl-1-phenylhexyl)-2,3,5-trimethylbenzoquinone

6-(6-methoxycarbonyl-1-phenylhexyl)-2,3,5-trimethylbenzoquinone

seratrodast
112665-43-7

seratrodast

seratrodast aminoethyl ester

seratrodast aminoethyl ester

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dmap / dichloromethane; N,N-dimethyl-formamide / 20 °C / Cooling with ice
2: hydrogenchloride / dichloromethane; ethyl acetate / 2 h / 20 °C / Cooling with ice
View Scheme

112665-43-7Related news

Antagonism of the TXA2 receptor by Seratrodast (cas 112665-43-7) : A structural approach07/26/2019

The crystal structure of seratrodast (AA-2414), a potent thromboxane A2 (TXA2) receptor antagonist, served as starting point to docking studies with the modeled human TXA2 receptor. This structural approach provides rational basis for the design of new antagonists within the aryl sulfonamide family.detailed

A kinetic and thermodynamic study of Seratrodast (cas 112665-43-7) polymorphic transition by isothermal microcalorimetry07/25/2019

The development of isothermal microcalorimetry to a study of the kinetic and thermodynamics of polymorphic transitions in seratrodast ((±)-7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid) Form II is reported. Sieved samples of Form II were allowed to convert to Form I, in a reac...detailed

High-performance liquid chromatographic determination of Seratrodast (cas 112665-43-7) and its metabolites in human serum and urine07/23/2019

A high-performance liquid chromatographic (HPLC) method was developed for the simultaneous determination of seratrodast, a new antiasthmatic drug, and its metabolites (M-I to M-III) in human serum and urine. The method for serum and urine with and without enzymatic hydrolysis using β-glucuronid...detailed

112665-43-7Relevant articles and documents

Catalytic Redox Chain Ring Opening of Lactones with Quinones to Synthesize Quinone-Containing Carboxylic Acids

Xu, Xiao-Long,Li, Zhi

, p. 5078 - 5081 (2019/09/03)

Catalytic ring opening of five- to eight-membered lactones with quinones is achieved through a redox chain mechanism. With low loading of a simple metal triflate Lewis acid catalyst and a chain initiator, C-H bonds of many quinones were efficiently functionalized with carboxylic acid-containing side chains. This method also features 100% atom economy and wide substrate scope. A novel route to the anti-asthma drug Seratrodast was developed. Mechanism study suggests that the redox chain reaction likely undergoes a carbocation intermediate.

Synthetic method for drug 7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid

-

Paragraph 0013; 0015-0026, (2018/07/30)

The invention discloses a synthetic method for the drug 7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid. The synthetic method comprises the following steps: adding 1,4-dimethoxy-2,5,6-trimethylbenzene and a sodium nitrate solution into a reaction vessel, controlling a stirring speed, carrying out heating, then adding aluminum isopropoxide, and continuing reaction; and carrying outheating, adding a sodium sulfate solution, adding potassium peroxydisulfate in batches within a certain period of time, controlling a stirring speed, adding niobium pentoxide powder, continuing the reaction, carrying out cooling, adding a potassium chloride solution, subjecting the solution to layering to separate an oil layer, washing the oil layer with an ethylene glycol solution, then washing the oil layer with a chloroform solution, carrying out recrystallization in a propargyl alcohol solution, and then carrying out dehydration with dehydrating agent to obtain the finished 7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid.

Indium-catalyzed synthesis of keto esters from cyclic 1,3-diketones and alcohols and application to the synthesis of seratrodast

Kuninobu, Yoichiro,Kawata, Atsushi,Noborio, Taihei,Yamamoto, Syun-Ichi,Matsuki, Takashi,Takata, Kazumi,Takai, Kazuhiko

scheme or table, p. 941 - 945 (2010/07/07)

Esterification reactions from cyclic 1,3-diketones and alcohols are carried out in the presence of several Lewis acids. In particular, indium(III) triflate, In(OTf)3, iron(III) triflate, Fe-(OTf)3, copper(II) triflate, Cu(OTf)2, and silver(I) triflate, AgOTf, show high catalytic activities. These reactions proceed through the carbon-carbon bond cleavage by a retro-aldol reaction and were found to be highly regioselective even in the presence of other functional groups. This type of reaction can also be applied to the preparation of the keto esters during the synthesis of seratrodast, which is an antiasthmatic and eicosanoid antagonist.

Method of treating preeclampsia

-

, (2008/06/13)

Straight-chain alkanoic acids, substituted at the Ω-carbon atom by a substituted phenyl, naphthyl, furyl, or thienyl group and by a substituted 1,4-benzoquinon-2-yl group are effective in the therapy or prophylaxis of conditions associated with lipid peroxide injury to vascular endothelium particularly preeclampsia and eclampsia in pregnant females.

Process for preparing diphenylmethane compounds

-

, (2008/06/13)

A diphenylmethane compound (III) can be produced in a good yield by allowing a phenol compound (I) to react with a stilbene compound (II) in the presence of methanesulfonic acid STR1

Quinone derivatives, their production and use

-

, (2008/06/13)

Quinone derivatives of the general formula: STR1 (wherein R1 and R2 are the same or different, and independently are a hydrogen atom or a methyl or methoxy group, or R1 and R2 combine with each other to represent --CH=CH--CH=CH--R3 is a hydrogen atom or a methyl group; R4 is an aliphatic, aromatic or heterocyclic group which may be substituted; R5 is a methyl or methoxy group, a hydroxymethyl group which may be substituted or a carboxyl group which may be esterified or amidated; Z is a group represented by --C=C--, --CH=CH--, STR2 n is an integer of 0 to 10; m is an integer of 0 to 3; k is an integer of 0 to 5, provided, however, that in the case of m being 2 or 3, Z and k can vary arbitrarily within the bracketed repeating units) are novel compounds, possess metabolism ameliorating action for polyunsaturated fatty acids, particularly production inhibitory activity of lipid peroxides (antioxidant activity), thromboxane A2 receptor antagonism, or production inhibitory activity of 5-lipoxygenase metabolites in mammals, and of use as drugs, such as antiasthmatic, antiallergic agent and cerebral-circulatory metabolism ameliorating agent.

Quinones. 4. Novel eicosanoid antagonists: Synthesis and pharmacological evaluation

Shiraishi,Kato,Terao,Ashida,Terashita,Kito

, p. 2214 - 2221 (2007/10/02)

A new series of ω-phenyl-ω-quinonylalkanoic acids and related compounds was synthesized. The compounds were tested for their inhibitory effects on U-44069-induced contraction of the rabbit aorta. (±)-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid (4d) (AA-2414) with pA2 value of 8.28 was one of the most potent compounds. Compound 4d inhibited U-46619-induced contraction of the guinea pig lung (pA2 = 8.29) and U-44069-induced aggregation of the guinea pig platelet (IC50 = 3.5 x 10-7 M). Compound 4d displaced the binding of [3H]U-46619 to guinea pig platelets (IC50 = 7.4 x 10-9 M). Compound 4d also showed very potent inhibitory effects with an MED of 0.3 mg/kg (po) on U-46619-, LTD4-, PAF-, or IgG1-induced bronchoconstriction in guinea pigs. The enantiomers of 4d were prepared. The R-(+) isomer 8a was active in both in vitro and in vivo tests, but the S-(-) isomer 8b was much less active. We concluded that the antiasthmatic effects of 4d were based mainly on the TXA2 receptor antagonistic action. In addition, compound 4d showed potent inhibitory effects on PGD2-, PGF(2α)-, and 11-epi-PGF(2α)-induced contraction of the guinea pig tracheal strips. The diverse inhibitory effects might be expressed in terms of eicosanoid-antagonistic activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 112665-43-7